Hexagon Nutrition Reports Q1 FY27 Consolidated Revenue of ₹1.04 Billion

MUMBAI — Hexagon Nutrition Limited reported its consolidated financial results for the first quarter ended June 30, 2026, marking its first full quarterly earnings filing following its public listing. The Mumbai-based nutrition and clinical product manufacturer posted consolidated revenue from operations of ₹1,043.06 million (₹1.04 billion) and a consolidated net profit after tax of ₹80.73 million (₹80.7 million).

The quarterly report, approved during the Board of Directors meeting held on August 12, 2026, represents a year-on-year increase in operational performance compared to the restated consolidated revenue of ₹728.61 million and net profit of ₹64.55 million recorded in the corresponding quarter ended June 30, 2025.

Financial Performance and Operational Breakdown

According to the regulatory filings submitted to the National Stock Exchange of India Limited and BSE Limited, total consolidated income for the quarter reached ₹1,063.84 million, up from ₹742.37 million in Q1 FY26.

On a standalone basis, Hexagon Nutrition registered revenue from operations of ₹1,014.02 million for Q1 FY27, compared to ₹632.57 million in Q1 FY26 and ₹984.71 million in Q4 FY26. Standalone net profit stood at ₹98.34 million, reflecting a increase from ₹59.69 million reported in the corresponding prior-year period.

Total consolidated expenses for the quarter rose to ₹958.45 million. Material consumption costs totaled ₹670.86 million, while employee benefits expenses were recorded at ₹136.11 million.

Key Corporate Developments and Corporate Actions

In addition to approving the Q1 FY27 financial performance, the Board of Directors recommended a final dividend of ₹0.30 (30 paise) per equity share of face value ₹1.00 each for the financial year ended March 31, 2026. The record date for determining shareholder eligibility for the dividend payout has been fixed for Tuesday, September 15, 2026, subject to approval at the 33rd Annual General Meeting scheduled for September 22, 2026.

The board approved several key administrative decisions:

• Executive Leadership: Recommended the re-appointment of Mr. Arun Purushottam Kelkar as Chairman & Executive Director for a five-year term effective September 28, 2026, and appointed Mr. Raghunath Sawant as an Additional Executive Director for five years starting August 12, 2026.

• Capital Restructuring: Noted the conversion of outstanding Compulsorily Convertible Preference Shares (CCPS) into equity shares on April 20, 2026, increasing paid-up equity share capital to ₹122.92 million.

• Facility Restructuring: Disclosed the phased decommissioning and operational restructuring of its premix manufacturing facility located in Nashik, Maharashtra. Management stated this post-quarter event carries no financial impact on Q1 FY27 results.

• Committee Dissolution: Formally dissolved its IPO Committee following the successful listing of its shares on the NSE and BSE on June 12, 2026.

Official Sources Section

Statements, operational metrics, and governance changes cited in this release were confirmed through official regulatory filings submitted under Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Primary documentation originates from the board outcome report released by the company secretary to the Securities and Exchange Board of India and public stock exchanges.

Quote Section

According to official filings submitted by Vedanti Vartak, Company Secretary and Compliance Officer at Hexagon Nutrition Limited:

"The Board of Directors at their meeting held on Wednesday, August 12, 2026, inter alia, approved the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026. Further, the board recommended a final dividend of 0.30 Paise per Equity Share of face value of ₹1/- each for the financial year ended March 31, 2026, subject to shareholder approval."

Why It Matters

The Q1 FY27 results provide market participants with the first clear, post-IPO quarterly performance metrics for Hexagon Nutrition. Following its ₹138.87 crore initial public offering conducted via 100% Offer for Sale (OFS), the firm's balance sheet transparency and operational expansion in the specialized nutrition market remain under evaluation by retail and institutional investors. Furthermore, corporate governance revisions and international subsidiary management reflect strategic adjustments to align with public market listing standards.

Key Facts at a Glance

• Consolidated Revenue: ₹1,043.06 million in Q1 FY27 vs ₹728.61 million in Q1 FY26.

• Consolidated Net Profit: ₹80.73 million for the quarter ended June 30, 2026.

• Recommended Dividend: ₹0.30 per equity share with record date set for September 15, 2026.

• Public Listing Date: Shares listed on NSE and BSE on June 12, 2026.

• Annual General Meeting: 33rd AGM scheduled for Tuesday, September 22, 2026 via video conferencing.

Frequently Asked Questions

What was Hexagon Nutrition's revenue in Q1 FY27?

Hexagon Nutrition reported consolidated revenue from operations of ₹1,043.06 million (₹1.04 billion) for the June quarter.

How much net profit did Hexagon Nutrition report for the quarter?

The company registered a consolidated net profit after tax of ₹80.73 million (₹80.7 million) for Q1 FY27.

Did the company declare any dividend for shareholders?

Yes, the Board of Directors recommended a final dividend of ₹0.30 per equity share of face value ₹1.00 for FY26, with a record date of September 15, 2026.

When were Hexagon Nutrition's shares listed on stock exchanges?

Hexagon Nutrition Limited officially listed its shares on the National Stock Exchange of India (NSE) and BSE Limited on June 12, 2026.

Source: Hexagon Nutrition Limited Regulatory Filing to NSE/BSE